Current Neuro-Oncology

Volume 27 Number 7
10 March 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 7, 10 March

Siddiqui H, Shaukat S, Kadri S, Saeed K, Mehmood T.
Radiological Response Assessment of Intracranial Meningioma after Cyberknife Stereotactic Radiosurgery.
J Coll Physicians Surg Pak. 2025 Mar;35(3):274-277. doi: 10.29271/jcpsp.2025.03.274. PMID: 40055157. Observational study. ˍ

Guo G, Zhang Z, Zhang J, Wang D, Xu S, Wu S, Deng K, Bu Y, Sheng Z, Yu J, Gao Y, Yan Z, Zhao R, Wang M, Li T, Bu X.
Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study.
Cancer Med. 2025 Mar 1;14(5):e70733. doi: 10.1002/cam4.70733? PMID: 40022576. Observational study. ˍ

Ruella M, Caffaratti G, Yorio F, Muggeri A, Del Pont FM, Domecq L, Mormandi R, Cervio A.
Ventricular opening in High-Grade Glioma surgery. Impact on surgical, functional outcomes, and survival rates. Experience in a Latin-American center.
Clin Neurol Neurosurg. 2025 Mar 1;250:108819. doi: 10.1016/j.clineuro.2025.108819. PMID: 40037215. Observational study˰ ˍ

Dasgupta A, Sawant S, Chatterjee A, Gota V, Sahu A, Choudhari A, Bhattacharya K, Puranik A, Dev I, Moiyadi A, Shetty P, Singh V, Menon N, Epari S, Sahay A, Shah A, Bano N, Shaikh F, Jirage A, Gupta T.
Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME).
Cancer Med. 2025 Mar 2;14(5):e70657. doi: 10.1002/cam4.70657? PMID: 40025673. Interventional study protocol. ˍ

Kawauchi D, Ohno M, Sugino H, Ito K, Fuse K, Yoshida A, Kubo Y, Honda-Kitahara M, Yanagisawa S, Ohmura T, Aoki T, Kawanishi A, Sakuramachi M, Igaki H, Narita Y.
Utility of [18F]fluciclovine PET/MRI for identifying the optimal biopsy target region, helping to avoid underdiagnosis in patients with glioblastoma: illustrative case.
J Neurosurg Case Lessons. 2025 Mar 3;9(9):CASE24677. doi: 10.3171/CASE24677. PMID: 40030156. Case report. ˍ

Olson J, Reddy D, Cai DX.
Multiple meningiomas of different variants in a single patient: illustrative cases.
J Neurosurg Case Lessons. 2025 Mar 3;9(9):CASE24359. doi: 10.3171/CASE24359. PMID: 40030164. Case report. ˍ

*Li X, Kim HJ, Yoo J, Lee Y, Nam CH, Park J, Lee ST, Kim TM, Choi SH, Won JK, Park SH, Ju YS, Park JB, Kim SH, Chang JH, Wu HG, Park CK, Lee JH, Kang SG, Lee JH.
Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.
Mol Cancer. 2025 Mar 4;24(1):64. doi: 10.1186/s12943-025-02273-2. PMID: 40033380. Laboratory investigation. ˍ

Luo W, Sun C, Jiang Z, Zhang R, Zhang W, Yu S.
A 6-year-old female with synchronous cerebellar and thalamic masses.
Brain Pathol. 2025 Mar 4:e70005. doi: 10.1111/bpa.70005? PMID: 40038864. Case report. ˍ

Ando Y, Yanagisawa S, Ohno M, Kurihara H, Ito K, Ichimura M, Anjo K, Inaba M, Nagasaka Y, Sadachi R, Shibata T, Okita N, Nakamura K, Matsumoto H, Yoshii Y, Narita Y.
Efficacy of radioactive hypoxia-targeting therapeutic agent ⁶⁴Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.
Jpn J Clin Oncol. 2025 Mar 5:hyaf026. doi: 10.1093/jjco/hyaf026. PMID: 40042578. Interventional study protocol˰ ˍ

*Fares J, Wan Y, Gurung B, Nazar T, Mair R, Joannides A, Santarius T, Matys T, Price SJ.
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04991-5. PMID: 40045105. Observational study. ˍ

Klungtvedt V, Aunan-Diop JS, Poulsen FR, Pedersen CB, Wismann J, Wang EW, Dahlrot RH, Halle B.
Radiotherapy for WHO grade 1 and 2 Intracranial Meningiomas - A Retrospective Analysis of Efficacy.
World Neurosurg. 2025 Mar 5:123858. doi: 10.1016/j.wneu.2025.123858. PMID: 40054846. Observational study. ˍ

Shireman JM, Distler E, Schepp C, Tao Y, McCarthy L, Kasulabada V, Dey M.
Impact of pregnancy on the treatment and outcomes of glioma: a cohort study.
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04961-x. PMID: 40042713. Observational study˰ ˍ

Faraj CA, McCutcheon IE, Gubbiotti MA, Perni S, Gule-Monroe MK, Akdemir K, Clark VE, Bander ED, Loghin ME, Prabhu SS, Lang FF, Weinberg JS.
Extra-central nervous system metastasis from high-grade glioma: a single-institution experience.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04977-3. PMID: 40055259. Observational study˰ ˍ

Lira MC, Vanpouille-Box C, De Martino M.
Harnessing FLASH irradiation to improve immunotherapy of medulloblastoma.
Trends Cancer. 2025 Mar 6:S2405-8033(25)00053-6. doi: 10.1016/j.trecan.2025.02.005. PMID: 40055118. Comment˰ ˍ
RELATED ARTICLE
Ni H, Reitman ZJ, Zou W, Akhtar MN, Paul R, Huang M, Zhang D, Zheng H, Zhang R, Ma R, Ngo G, Zhang L, Diffenderfer ES, Motlagh SAO, Kim MM, Minn AJ, Dorsey JF, Foster JB, Metz J, Koumenis C, Kirsch DG, Gong Y, Fan Y.
FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.
Nat Cancer. 2025 Feb 5. doi: 10.1038/s43018-025-00905-6. PMID: 39910249. Laboratory investigation˰ ˍ

Mirone G, Picariello S, Russo C, Cicala D, Spennato P, Onorini N, Quaglietta L, Covelli E, Cinalli G.
Magnetic resonance guided laser interstitial thermal therapy in pediatric brain tumors: an institutional case series.
J Neurosurg Sci. 2025 Mar 6. doi: 10.23736/S0390-5616.24.06381-1. PMID: 40047450. Observational study˰ ˍ

Neth BJ, Kraft RM, Eschbacher KL, Johnson DR, Decker PA, Sener UT, Uhm JH, Ruff MW, Schwartz JD, Breen WG, Maqbool MA, Daniels DJ, Burns TC, Parney IF, Raghunathan A, Kizilbash SH.
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04994-2. PMID: 40048040. Observational study˰ ˍ

Ni CX, Lin RL, Yao DQ, Ma FZ, Shi YT, He YY, Song Y, Yang G, Jiang RF, Wáng YXJ.
Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas.
BMC Med Imaging. 2025 Mar 6;25(1):79. doi: 10.1186/s12880-025-01605-4. PMID: 40050759. Observational study. ˍ

Brenner AJ, Patel T, Bao A, Phillips WT, Michalek JE, Youssef M, Weinberg JS, Kamiya Matsuoka C, Hedrick MH, LaFrance N, Moore M, Floyd JR.
Convection enhanced delivery of Rhenium (¹⁸⁶Re) Obisbemeda (¹⁸⁶RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial.
Nat Commun. 2025 Mar 7;16(1):2079. doi: 10.1038/s41467-025-57263-1. PMID: 40055350. Interventional study. ˍ

Kim MM, Aryal MP, Suresh K, Rosen BS, Parmar H, You D, Leung D, Clarke N, Fortunato J, Al-Holou W, Heth J, Altshuler D, Hollon T, Edwards DM, Wahl DR, Lawrence TS, Cao Y.
A phase II study of multiparametric MR-guided high-dose response-adaptive radiotherapy with concurrent temozolomide in patients with newly diagnosed glioblastoma: Results from an interim analysis.
Int J Radiat Oncol Biol Phys. 2025 Mar 8:S0360-3016(25)00160-9. doi: 10.1016/j.ijrobp.2025.02.020. PMID: 40058709. Interventional study˰ ˍ

Liang L, Chen L, Ni C, Shi W, Zhou Z, Chen S, Zhu W, Liu J, Qiu X, Lin W, Zhang J, Qin Z, Wang Y.
Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China.
Chin Neurosurg J. 2025 Mar 7;11(1):5. doi: 10.1186/s41016-025-00391-w. PMID: 40055813. Observational study. ˍ

Ruella ME, Caffaratti G, Del Pont FM, Muggeri A, Yorio F, Mormandi R, Cervio A.
Ependymal invasion in High-Grade Glioma. Impact on surgical, functional outcomes, and survival rates. Experience in a Latin-American center.
Neurosurg Rev. 2025 Mar 7;48(1):286. doi: 10.1007/s10143-025-03445-w. PMID: 40050499. Observational study˰ ˍ

Cerretti G, Bosio A, Librizzi G, Pintacuda G, Caccese M, Salvalaggio A, Zoccarato M, Parisi A, Padovan M, Maccari M, Cavallin F, Bellu L, Pasqualetti F, Ius T, Denaro L, Volpin F, Coppola M, Lonardi S, Lombardi G.
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-04992-4. PMID: 40063186. Observational study. ˍ

Pereira R, Mackay A, Grabovska Y, Bradley A, Bloom T, Nicoll J, Boche D, Procter J, Maybury M, Schagen J, Walker L, Roncaroli F, Karabatsou K, Ogunbiyi O, van Dalen T, Sidpra J, Rossi S, Miele E, Ziegler DS, Shi Z, Jacques TS, Hargrave D, Zebian B, Bleil C, Yates J, Norton E, Mandeville H, Creak A, Welsh L, Marshall L, Carceller F, Vaidya SJ, Reisz Z, Al-Sarraj S, Mastronuzzi A, Carai A, Vinci M, Kurian KM, Ng HK, Brandner S, Jones C, Clarke M.
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations.
Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-1256. PMID: 40063504. Translational study. ˍ

Shroff K, Shetty P, Singh V, Epari S, Sahay A, Moiyadi A.
Clinical value of optimizing extent of resection in adult diffuse gliomas.
Clin Neurol Neurosurg. 2025 Mar 10;251:108838. doi: 10.1016/j.clineuro.2025.108838. PMID: 40080942. Observational study˰ ˍ